Liminal BioSciences Inc. PFSCF

RE:RE:100M$ cash voucher (non dilutive) on 90M$ market cap

[PLITheOne]

How much of that sale will SALP consume for holding the IP?

stockbuphoon wrote:

$3.45 is better than $2.86 but it's not 2x or 3x times the $4 that you were pumping...  let's see where it goes but without R&D milestones except preclinical. Nothing on 4050/ Fez MAD studies for new indications to take to clinic and they then need to get clinical trial design complete working with FDA and recruit patients, etc. Not enough runway... 

 

tommyjones1 wrote:

 

sp will 2x,3x easy thats why these clowns want your shares. Now, when is it coming? See latest NR: the Rare Pediatric Disease Priority Review Voucher ("PRV") by its subsidiary, Prometic Biotherapeutics Inc. ("PBT"), which would be payable to Liminal prior to closing the divestment of its remaining plasma-derived therapeutics business operated through PBT (the "Second Closing").

 

coming anytime...

-----------------------------------------------------------------------------------------------------------------

everybody on this board and the market manipulators want your shares... this stock wil ride high next days... 

With this FDA ok, we can sell that riplazym voucher...market price is between 80M$-120M$ u.s., so lets say 100M$ u.s., we get 70%.... 70M$ u.s. + 17M$ u.s. we cashed already, around 100M$ can$ , lmnl will be able to execute big time and do more deals like this (sell or partner), we gat some in the oven already. Doyour dd. Dont listen to the clown$ operating on this board.  They are here for $$$... accumulation time....